Geraldine Delbes

Geraldine Delbes

Auto-generated profile, based on publicly available information

Geraldine Delbes

Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), Laval, Canada

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2022 in Environmental Research
Verified
Journal Article
Open access
VMV.L. Marlatt
V.L. Marlatt
SBS. Bayen
S. Bayen
DCD. Castaneda-Cortès
D. Castaneda-Cortès
GDG. Delbès
G. Delbès
PGP. Grigorova
P. Grigorova
GKG. Van Der Kraak
G. Van Der Kraak
Endocrine disrupting chemicals (EDCs) are ubiquitous in aquatic and terrestrial environments. The main objective of this review was to summarize the current knowledge of the impacts of EDCs on reproductive success in wildlife and humans. The examples selected often include a retrospective assessment of the knowledge of reproductive impacts over time to discern how the effects of EDCs have changed over the last several decades. Collectively, the evidence summarized here within reinforce the concept that reproduction in wildlife and humans is negatively impacted by anthropogenic chemicals, with several altering endocrine system function. These observations of chemicals interfering with different aspects of the reproductive endocrine axis are particularly pronounced for aquatic species and are often corroborated by laboratory-based experiments (i.e. fish, amphibians, birds). Noteworthy, many of these same indicators are also observed in epidemiological studies in mammalian wildlife and humans. Given the vast array of reproductive strategies used by animals, it is perhaps not surprising that no single disrupted target is predictive of reproductive effects. Nevertheless, there are some general features of the endocrine control of reproduction, and in particular, the critical role that steroid hormones play in these processes that confer a high degree of susceptibility to environmental chemicals. New research is needed on the implications of chemical exposures during development and the potential for long-term reproductive effects. Future emphasis on field-based observations that can form the basis of more deliberate, extensive, and long-term population level studies to monitor contaminant effects, including adverse effects on the endocrine system, are key to addressing these knowledge gaps.

1 March 2022 in Environmental Research
Verified
Journal Article
Open access
GDG. Delbes
G. Delbes
MBM. Blázquez
M. Blázquez
JFJ.I. Fernandino
J.I. Fernandino
PGP. Grigorova
P. Grigorova
BHB.F. Hales
B.F. Hales
VMV. Marlatt
V. Marlatt
Over the past century, evidence has emerged that endocrine disrupting chemicals (EDCs) have an impact on reproductive health. An increased frequency of reproductive disorders has been observed worldwide in both wildlife and humans that is correlated with accidental exposures to EDCs and their increased production. Epidemiological and experimental studies have highlighted the consequences of early exposures and the existence of key windows of sensitivity during development. Such early in life exposures can have an immediate impact on gonadal and reproductive tract development, as well as on long-term reproductive health in both males and females. Traditionally, EDCs were thought to exert their effects by modifying the endocrine pathways controlling reproduction. Advances in knowledge of the mechanisms regulating sex determination, differentiation and gonadal development in fish and rodents have led to a better understanding of the molecular mechanisms underlying the effects of early exposure to EDCs on reproduction. In this manuscript, we review the key developmental stages sensitive to EDCs and the state of knowledge on the mechanisms by which model EDCs affect these processes, based on the roadmap of gonad development specific to fish and mammals.

12 October 2023 in Nature Reviews Urology
Verified
Journal Article
Closed access
PDF file
SKSarah Kimmins
Sarah Kimmins
RARichard A Anderson
Richard A Anderson
CBChristopher L. R. Barratt
Christopher L. R. Barratt
HBHermann M. Behre
Hermann M. Behre
SCSarah R. Catford
Sarah R. Catford
MOMoira O'Bryan
Moira O'Bryan

2 September 2018 in Andrology
Verified
Journal Article
Closed access
PDF file
MLM. F. Lusignan
M. F. Lusignan
XLX. Li
X. Li
BHB. Herrero
B. Herrero
GDG. Delbes
G. Delbes
PCP. T. K. Chan
P. T. K. Chan

1 June 2018 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
ATAmélie R. Tremblay
Amélie R. Tremblay
GDGeraldine Delbes
Geraldine Delbes

1 June 2017 in Reproduction
Verified
Journal Article
Closed access
PDF file
HBHermance Beaud
Hermance Beaud
APAns van Pelt
Ans van Pelt
GDGeraldine Delbes
Geraldine Delbes
Anticancer drugs, such as alkylating agents, can affect male fertility by targeting the DNA of proliferative spermatogonial stem cells (SSC). Therefore, to reduce such side effects, other chemotherapeutics are used. However, less is known about their potential genotoxicity on SSC. Moreover, DNA repair mechanisms in SSC are poorly understood. To model treatments deprived of alkylating agents that are commonly used in cancer treatment, we tested the impact of exposure to doxorubicin and vincristine, alone or in combination (MIX), on a rat spermatogonial cell line with SSC characteristics (GC-6spg). Vincristine alone induced a cell cycle arrest and cell death without genotoxic impact. On the other hand, doxorubicin and the MIX induced a dose-dependent cell death. More importantly, doxorubicin and the MIX induced DNA breaks, measured by the COMET assay, at a non-cytotoxic dose. To elucidate which DNA repair pathway is activated in spermatogonia after exposure to doxorubicin, we screened the expression of 75 genes implicated in DNA repair. Interestingly, all were expressed constitutively in GC-6spg, suggesting great potential to respond to genotoxic stress. Doxorubicin treatments affected the expression of 16 genes (>1.5 fold change; P < 0.05) involved in cell cycle, base/nucleotide excision repair, homologous recombination and non-homologous end joining (NHEJ). The significant increase in CDKN1A and XRCC1 suggest a cell cycle arrest and implies an alternative NHEJ pathway in response to doxorubicin-induced DNA breaks. Together, our results support the idea that undifferentiated spermatogonia have the ability to respond to DNA injury from chemotherapeutic compounds and escape DNA break accumulation.